Navigation Links
Cedars-Sinai opens new Induced Pluripotent Stem Cell Core Production Facility

LOS ANGELES The Cedars-Sinai Regenerative Medicine Institute has opened a new Induced Pluripotent Stem Cell (iPSC) Core Facility to produce powerful cells capable of making all tissues of the body from adult human skin cells.

One of the first to open in California, cells produced by the Cedars-Sinai core will be used in research funded by the National Institutes of Health and the California Institute for Regenerative Medicine. The cells will be critical for innovative research aimed at increasing our understanding of human diseases and genetic disorders, and the quest for new treatments.

"The opening of the Cedars-Sinai Stem Cell Core Facility underscores what an exciting time this is in regenerative medicine," said Shlomo Melmed, MD, senior vice president of academic affairs and dean of the faculty at Cedars-Sinai. "It also is an example of Cedars-Sinai's deep commitment to the scientific research that will be translated into tomorrow's leading-edge treatments."

The new facility will use the latest technology to generate induced pluripotent stem cells from a patient skin scraping. The induced pluripotent stem cells can be replicated indefinitely and have biological properties similar to embryonic stem cells. These "blank slate" cells can then be turned into any kind of differentiated cell, such as a brain cell or an eye cell or a liver cell.

Although iPS cells were first produced only three years ago, they have quickly become valuable research tools. Clinicians can take skin cells from patients with specific life threatening diseases. Then, Regenerative Medicine Institute scientists can create iPS cells from them and then generate so-called "disease in a dish" models that enable them to more easily identify effective therapies.

"Now, for the first time, we can study human diseases by creating a laboratory specimen of afflicted cells," said Clive Svendsen, PhD, director of the Cedars-Sinai Regenerative Medicine Institute. "We have been funded by both the National Institutes of Health and the California Institute of Regenerative Medicine to do this work which has the potential to revolutionize medicine."

For example, the Stem Cell Core Facility already is supplying iPS cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington's disease, an incurable neurodegenerative genetic disorder that affects muscle coordination and some cognitive functions, such as memory. With funding from the California Institute for Regenerative Medicine, the Cedars-Sinai core has also generated iPS cells from children with spinal muscular atrophy a lethal disease that leaves children paralyzed. These are being used to develop novel drug compounds to treat this devastating disorder,

"We are very excited to launch this new core facility," said Dhruv Sareen, PhD, the core's new director. "It will enable exciting studies across the entire Cedars-Sinai Medical Center and we look forward to much productive collaboration."


Contact: Sally Stewart
Cedars-Sinai Medical Center

Related biology news :

1. IronKey Opens New European Office
2. Singapore opens Fusionopolis, its second major R&D hub in 5 years
3. Climate change opens new avenue for spread of invasive plants
4. Orangutans spontaneous whistling opens new chapter in study of evolution of speech
5. Registration Opens for 2009 Force Protection Equipment Demonstration
6. Unexpected finding opens up new way to stop autoimmune diseases and transplant rejection
7. A research work on molluscs nacre opens new doors for its possible use in biomedicine
8. The Earth Observatory of Singapore devoted to the study of earth sciences officially opens
9. Tiny tool to control growing blood vessels opens new potential in tumor research
10. Mobile Communication Market Opens up for Biometrics - Precise Biometrics Awarded 1st Prize at GSMA World Mobile Congress
11. Genital stimulation opens door for cryptic female choice in tsetse flies
Post Your Comments:
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... ... 2017 , ... For the second time in three years, ... Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October 10th, ... mission is to change the trajectory of STEM education in America by dramatically ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
Breaking Biology Technology: